Boehringer Ingelheim

Binger Str. 173
55218 Ingelheim


Contact WebSite

Article

Boehringer Ingelheim Leadership Changes
17.04.2025 • News

Boehringer Ingelheim Leadership Changes

Shashank Deshpande, member of the Board of Managing Directors, has been appointed Chairman of the Board of Managing Directors.

Boehringer Ingelheim Opens New R&D Center in Basel
07.04.2025 • News

Boehringer Ingelheim Opens New R&D Center in Basel

NBE Therapeutics (NBE), a wholly owned subsidiary of  Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel.

Boehringer Ingelheim Expands Cancer Research at Vienna Site
30.09.2024 • News

Boehringer Ingelheim Expands Cancer Research at Vienna Site

On Sep. 25, German biopharma company Boehringer Ingelheim opened its new 11,000 sqm Angelika Amon Research Building at its site in Vienna, Austria. According to Boehringer Ingelheim, the investment of around €60 million is further proof of the company's commitment to cancer research.

Boehringer to Expand Greek Production Site for New Medicines
19.01.2024 • News

Boehringer to Expand Greek Production Site for New Medicines

German drugmaker Boehringer Ingelheim is investing €120 million in an upgrade and expansion of its facility in Koropi, Greece, that will increase the company's capacity to produce existing and new medicines. Main disease areas, Boehringer said, include cardio-renal-metabolic (CRM) diseases, mental health, and pulmonary fibrosis.

Boehringer Ingelheim, Evotec and BioMérieux Link on AMR
14.07.2022 • News

Boehringer Ingelheim, Evotec and BioMérieux Link on AMR

German biopharma Boehringer Ingelheim, compatriot CDMO Evotec and French diagnostics firm BioMérieux have formed a joint venture to develop a new approach to fight the rise of antibiotic-resistant infections.